All News

podcast logo

RheumNow Podcast – ACR 2020 Epilogue (11.20.20)

Jack Cush, MD

Dr. Jack Cush reviews a few more ACR 2020 abstracts and presents a new plan to learn or take in ACR20 content.

Read Article
ACR Mon

ACR20 - Day 4 Report

Jack Cush, MD

Here are my highlights from day four, Monday, of the ACR 2020 Convergence. 



Vaccine Immunogenicity with Tofacitinib

Read Article
audience learn

ACR20 – Day 1 Report

Jack Cush, MD

Friday was the first full day of scientific sessions at the 2020 Virtual ACR/ARP annual meeting. Here are my highlights from day one:

Read Article
ACR20 Podcast

QD Clinic Podcast - 106 thru 109

Jack Cush, MD

Here is the last of our QD Clinics in Podcast form, just before we start ACR2020 coverage.



In this compilation from the past week we talk about



- HIV and arthritis



- Hyperuricemia in PsA



- An odd kind of dermatomyositis

Read Article
infx.pneumonia.jpg

TNF Inhibitor Associated Infectious Risk Greatest in First 6 Months

Jack Cush, MD

The risk of serious infections (SIE) in RA patients given anti-TNF (TNFi) therapy is not static, instead it has been shown to be greatest in the first 6 months of use according to a recent report in Rheumatology. 

Read Article
podcast logo

RheumNow Podcast – ACR 20 is Coming to Town (10.30.20)

Jack Cush, MD

Dr Jack Cush overviews the RheumNow commitment, upcoming bonus coverage of ACR20 and the good news and journal reports from the past week on RheumNow.com

Read Article
FDA.jpg (keep)

FDA Hearing on COVID-19 Vaccines

Jack Cush, MD

Yesterday the Food and Drug Administration's (FDA) "Vaccines and Related Biological Products Advisory Committee" conve

Read Article
Read our recap on Tofacitinib for Ankylosing Spondylitis by Sheila Marie Reyes ( @RHEUMarampa) #ACR20 https://t.co/E9zJXuq1u4 https://t.co/nmBRnkwOif

Links:

Dr. John Cush RheumNow ( View Tweet)
Another great late-breaking asbtract: #HerpesZoster in patients w/ #rheumatoidarthritis taking #upadacitinib #JAKinhibitor -HZ events more common in patients taking 30mg vs 15mg -HZ more common in UPA vs those taking ADA+MTX & MTX Abs#2002 #ACR20 @RheumNow https://t.co/tQ03wBueW5

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

@RheumNow #ACR20 abs1151 screening for inflammatory hyperferritinemia may be feasible but requires additional info: inflammatory huperferritinemia more likely to correlate with ⬆️IL18, AST&thrombocytosis while high CRP+ferritin more often seen in infectious etiology https://t.co/wiFPXepxpz

Olga Petryna DrPetryna ( View Tweet)
Congrats @sdlcrodriguez on a great presentation! Abs#1465: Combined #vaccination scheme leads to decreased incidence of Strep pneumoniae #infection in #rheumatoidarthritis patients taking b/tsDMARD. #ACR20 @RheumNow https://t.co/EwIj0PYbgI https://t.co/cqg8xtcB48

Links:

Mrinalini Dey DrMiniDey ( View Tweet)
It was a joy to discuss #infection in #rheumatic diseases, one of my favourite subspecialties, with @drjamesgalloway @KCLImmunoMicro. Hear his reflections on #COVID19 and highlights from the many great infection-related abstracts at #ACR20. @RheumNow https://t.co/KQ1NuKrQOI

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Autoimmune Disease Outcomes of Women with Breast Implants: A Population-Based Study https://t.co/Z6R8zRezfN #breastimplants #IMID an old chestnut

Links:

Peter Nash drpnash ( View Tweet)

Time-trend analysis in hospitalised #infection in #lupus -Incr. rate of hospitalised infections over time -#Sepsis surpassed #pneumonia as most common hospitalised infection in 2011-12; twice as many sepsis vs pneumonia by 2015-16 Abs#0980 #ACR20 @RheumNow https://t.co/M8xbMDFUTS https://t.co/ShogvxbhzN

Links:

Mrinalini Dey DrMiniDey ( View Tweet)
Wonderful Philip Hench Memorial Lecture from Prof Gerd Bursmester on the development of biologics in rheumatology from infections, the magic bullet, serendipity, perseverance, research to the present day @RheumNow #ACR20 #3S007 https://t.co/9H1AmZLTpJ
Dr. Antoni Chan synovialjoints ( View Tweet)
For patients with #rheumatic disease, what test do you request in the work-up for Latent TB infection? @RheumNow #ACR20

sheila RHEUMarampa ( View Tweet)

Patients with ARDs have incr. susceptibility to #infection. Real-world study shows suboptimal #influenza, #pneumococcal & #herpeszoster #vaccination coverage in these patients. Important to consider strategies to improve uptake. Abs#0541 #ACR20 @RheumNow https://t.co/GAapkzILvW

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Infectious disease physician, Dr. Eric Rubin, kicks off the ACR keynote address by reminding us that there are real alliances between Infectious Disease doctors and Rheumatologists in that inflammation can cause damage during infection! #ACR20 @RheumNow https://t.co/pcOS1HbfX7
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Determining safety of a vaccine requires NUMBERS (more subjects to detect rare, serious side effects) and TIME (longer trials to be able to detect more delayed side effects) per Dr. Eric Rubin’s (ID physician’s) keynote address at #ACR20 @RheumNow

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×